LEFT-VENTRICULAR HYPERTROPHY AS A RISK FACTOR for ARRHYTHMIAS in HEMODIALYSIS-PATIENTS

Detalhes bibliográficos
Autor(a) principal: Saragoca, Manoel A. [UNIFESP]
Data de Publicação: 1991
Outros Autores: Canziani, M. E. [UNIFESP], Cassiolato, José L., Gil, M. A. [UNIFESP], Andrade, J. L. [UNIFESP], Draibe, S. A. [UNIFESP], Martinez, E. E. [UNIFESP]
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Institucional da UNIFESP
Texto Completo: http://repositorio.unifesp.br/handle/11600/25174
http://dx.doi.org/10.1097/00005344-199117002-00032
Resumo: The contribution of left ventricular hypertrophy in determining ventricular arrhythmias (VAS) was studied in 81 chronic renal failure patients in chronic hemodialysis using two-dimensional echocardiographic and electrocardiogram Holter monitoring. the prevalence of LVH was 93% (96% in hypertensive and 87% in normotensive patients). the prevalence of VA was 48%. These arrhythmias were associated with increased cardiac mass, lack of potassium supplementation to the hemodialysis bath, and low K+ and PaO2 during dialysis. Severe forms of VA occurred in 19 of 78 patients, and the risk factors for this occurrence were (a) largely increased cardiac mass indices (exceeding in more than 40% the upper limit of normal for each sex) and (b) prolonged periods of time in hemodialysis treatment (34 +/- 5.5 vs. 17 +/- 2.7 months, p < 0.05). Changes in potassium or oxygen content of the blood were not significantly associated with the occurrence of severe forms of VA.
id UFSP_657c8f89477dc3212ac3d798dcc3c0e5
oai_identifier_str oai:repositorio.unifesp.br:11600/25174
network_acronym_str UFSP
network_name_str Repositório Institucional da UNIFESP
repository_id_str 3465
spelling Saragoca, Manoel A. [UNIFESP]Canziani, M. E. [UNIFESP]Cassiolato, José L.Gil, M. A. [UNIFESP]Andrade, J. L. [UNIFESP]Draibe, S. A. [UNIFESP]Martinez, E. E. [UNIFESP]Universidade Federal de São Paulo (UNIFESP)CENTROCOR2016-01-24T11:40:00Z2016-01-24T11:40:00Z1991-01-01Journal of Cardiovascular Pharmacology. Philadelphia: Lippincott-raven Publ, v. 17, p. S136-S138, 1991.0160-2446http://repositorio.unifesp.br/handle/11600/25174http://dx.doi.org/10.1097/00005344-199117002-0003210.1097/00005344-199117002-00032WOS:A1991FU76000032The contribution of left ventricular hypertrophy in determining ventricular arrhythmias (VAS) was studied in 81 chronic renal failure patients in chronic hemodialysis using two-dimensional echocardiographic and electrocardiogram Holter monitoring. the prevalence of LVH was 93% (96% in hypertensive and 87% in normotensive patients). the prevalence of VA was 48%. These arrhythmias were associated with increased cardiac mass, lack of potassium supplementation to the hemodialysis bath, and low K+ and PaO2 during dialysis. Severe forms of VA occurred in 19 of 78 patients, and the risk factors for this occurrence were (a) largely increased cardiac mass indices (exceeding in more than 40% the upper limit of normal for each sex) and (b) prolonged periods of time in hemodialysis treatment (34 +/- 5.5 vs. 17 +/- 2.7 months, p < 0.05). Changes in potassium or oxygen content of the blood were not significantly associated with the occurrence of severe forms of VA.ESCOLA PAULISTA MED SCH,DIV CARDIOL,BR-04023 São Paulo,BRAZILCENTROCOR,São Paulo,BRAZILESCOLA PAULISTA MED SCH,DIV CARDIOL,BR-04023 São Paulo,BRAZILWeb of ScienceS136-S138engLippincott-raven PublJournal of Cardiovascular PharmacologyLEFT VENTRICULAR HYPERTROPHYCARDIAC HYPERTROPHYVENTRICULAR ARRHYTHMIASCHRONIC RENAL FAILUREHEMODIALYSISLEFT-VENTRICULAR HYPERTROPHY AS A RISK FACTOR for ARRHYTHMIAS in HEMODIALYSIS-PATIENTSinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleinfo:eu-repo/semantics/openAccessreponame:Repositório Institucional da UNIFESPinstname:Universidade Federal de São Paulo (UNIFESP)instacron:UNIFESP11600/251742023-01-12 22:03:33.999metadata only accessoai:repositorio.unifesp.br:11600/25174Repositório InstitucionalPUBhttp://www.repositorio.unifesp.br/oai/requestopendoar:34652023-01-13T01:03:33Repositório Institucional da UNIFESP - Universidade Federal de São Paulo (UNIFESP)false
dc.title.en.fl_str_mv LEFT-VENTRICULAR HYPERTROPHY AS A RISK FACTOR for ARRHYTHMIAS in HEMODIALYSIS-PATIENTS
title LEFT-VENTRICULAR HYPERTROPHY AS A RISK FACTOR for ARRHYTHMIAS in HEMODIALYSIS-PATIENTS
spellingShingle LEFT-VENTRICULAR HYPERTROPHY AS A RISK FACTOR for ARRHYTHMIAS in HEMODIALYSIS-PATIENTS
Saragoca, Manoel A. [UNIFESP]
LEFT VENTRICULAR HYPERTROPHY
CARDIAC HYPERTROPHY
VENTRICULAR ARRHYTHMIAS
CHRONIC RENAL FAILURE
HEMODIALYSIS
title_short LEFT-VENTRICULAR HYPERTROPHY AS A RISK FACTOR for ARRHYTHMIAS in HEMODIALYSIS-PATIENTS
title_full LEFT-VENTRICULAR HYPERTROPHY AS A RISK FACTOR for ARRHYTHMIAS in HEMODIALYSIS-PATIENTS
title_fullStr LEFT-VENTRICULAR HYPERTROPHY AS A RISK FACTOR for ARRHYTHMIAS in HEMODIALYSIS-PATIENTS
title_full_unstemmed LEFT-VENTRICULAR HYPERTROPHY AS A RISK FACTOR for ARRHYTHMIAS in HEMODIALYSIS-PATIENTS
title_sort LEFT-VENTRICULAR HYPERTROPHY AS A RISK FACTOR for ARRHYTHMIAS in HEMODIALYSIS-PATIENTS
author Saragoca, Manoel A. [UNIFESP]
author_facet Saragoca, Manoel A. [UNIFESP]
Canziani, M. E. [UNIFESP]
Cassiolato, José L.
Gil, M. A. [UNIFESP]
Andrade, J. L. [UNIFESP]
Draibe, S. A. [UNIFESP]
Martinez, E. E. [UNIFESP]
author_role author
author2 Canziani, M. E. [UNIFESP]
Cassiolato, José L.
Gil, M. A. [UNIFESP]
Andrade, J. L. [UNIFESP]
Draibe, S. A. [UNIFESP]
Martinez, E. E. [UNIFESP]
author2_role author
author
author
author
author
author
dc.contributor.institution.none.fl_str_mv Universidade Federal de São Paulo (UNIFESP)
CENTROCOR
dc.contributor.author.fl_str_mv Saragoca, Manoel A. [UNIFESP]
Canziani, M. E. [UNIFESP]
Cassiolato, José L.
Gil, M. A. [UNIFESP]
Andrade, J. L. [UNIFESP]
Draibe, S. A. [UNIFESP]
Martinez, E. E. [UNIFESP]
dc.subject.eng.fl_str_mv LEFT VENTRICULAR HYPERTROPHY
CARDIAC HYPERTROPHY
VENTRICULAR ARRHYTHMIAS
CHRONIC RENAL FAILURE
HEMODIALYSIS
topic LEFT VENTRICULAR HYPERTROPHY
CARDIAC HYPERTROPHY
VENTRICULAR ARRHYTHMIAS
CHRONIC RENAL FAILURE
HEMODIALYSIS
description The contribution of left ventricular hypertrophy in determining ventricular arrhythmias (VAS) was studied in 81 chronic renal failure patients in chronic hemodialysis using two-dimensional echocardiographic and electrocardiogram Holter monitoring. the prevalence of LVH was 93% (96% in hypertensive and 87% in normotensive patients). the prevalence of VA was 48%. These arrhythmias were associated with increased cardiac mass, lack of potassium supplementation to the hemodialysis bath, and low K+ and PaO2 during dialysis. Severe forms of VA occurred in 19 of 78 patients, and the risk factors for this occurrence were (a) largely increased cardiac mass indices (exceeding in more than 40% the upper limit of normal for each sex) and (b) prolonged periods of time in hemodialysis treatment (34 +/- 5.5 vs. 17 +/- 2.7 months, p < 0.05). Changes in potassium or oxygen content of the blood were not significantly associated with the occurrence of severe forms of VA.
publishDate 1991
dc.date.issued.fl_str_mv 1991-01-01
dc.date.accessioned.fl_str_mv 2016-01-24T11:40:00Z
dc.date.available.fl_str_mv 2016-01-24T11:40:00Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.citation.fl_str_mv Journal of Cardiovascular Pharmacology. Philadelphia: Lippincott-raven Publ, v. 17, p. S136-S138, 1991.
dc.identifier.uri.fl_str_mv http://repositorio.unifesp.br/handle/11600/25174
http://dx.doi.org/10.1097/00005344-199117002-00032
dc.identifier.issn.none.fl_str_mv 0160-2446
dc.identifier.doi.none.fl_str_mv 10.1097/00005344-199117002-00032
dc.identifier.wos.none.fl_str_mv WOS:A1991FU76000032
identifier_str_mv Journal of Cardiovascular Pharmacology. Philadelphia: Lippincott-raven Publ, v. 17, p. S136-S138, 1991.
0160-2446
10.1097/00005344-199117002-00032
WOS:A1991FU76000032
url http://repositorio.unifesp.br/handle/11600/25174
http://dx.doi.org/10.1097/00005344-199117002-00032
dc.language.iso.fl_str_mv eng
language eng
dc.relation.ispartof.none.fl_str_mv Journal of Cardiovascular Pharmacology
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv S136-S138
dc.publisher.none.fl_str_mv Lippincott-raven Publ
publisher.none.fl_str_mv Lippincott-raven Publ
dc.source.none.fl_str_mv reponame:Repositório Institucional da UNIFESP
instname:Universidade Federal de São Paulo (UNIFESP)
instacron:UNIFESP
instname_str Universidade Federal de São Paulo (UNIFESP)
instacron_str UNIFESP
institution UNIFESP
reponame_str Repositório Institucional da UNIFESP
collection Repositório Institucional da UNIFESP
repository.name.fl_str_mv Repositório Institucional da UNIFESP - Universidade Federal de São Paulo (UNIFESP)
repository.mail.fl_str_mv
_version_ 1802764122197065728